Quality of surveillance for stage I testis cancer in the community

Journal of Clinical Oncology

Volumn 27, Issue 26, 2009, Pages 4327-4332

  Yu, Hua Yin ^a   Madison, Rodger A ^a   Setodji, Claude M ^a   Saigal, Christopher S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; GERM CELL TUMOR; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; IMAGING; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RECURRENCE RISK; TESTIS CANCER; TREATMENT OUTCOME; ADOLESCENT; AGED; DIAGNOSTIC IMAGING; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED; NEOPLASM; PATIENT ATTITUDE; STATISTICS; TESTIS TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC IMAGING; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PREFERRED PROVIDER ORGANIZATIONS; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 70349334505     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.9406     Document Type: Article

References (19)

1. de Wit R, Fizazi K: Controversies in the management of clinical stage I testis cancer. J Clin Oncol 24:5482-5492, 2006
2. Ernst DS, Brasher P, Venner PM, et al: Compliance and outcome of patients with stage 1 nonseminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres. Can J Urol 12:2575-2580, 2005
3. Nicolai N, Pizzocaro G: A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 154:1045-1049, 1995
4. Hao D, Seidel J, Brant R, et al: Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 160:768-771, 1998
5. Choo R, Sandler H, Warde P, et al: Survey of radiation oncologists: Practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United States. Can J Urol 9:1479-1485, 2002
6. Bagnell S, Choo R, Klotz LH, et al: Practice patterns of Canadian urologists in the management of stage I testicular seminoma. Can J Urol 11:2194-2199, 2004
7. Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 20:4448-4452, 2002
8. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Testicular Cancer V. 2.2008. http://www.nccn.org/professionals/ physician-gls/PDF/testicular.pdf
9. Groll RJ, Warde P, Jewett MAS: A comprehensive systematic review of testicular germ cell surveillance. Crit Rev Oncol Hematol 64:182-197, 2007
10. Gels ME, Hoekstra HJ, Sleijfer DT, et al: Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: A single-center 10-year experience. J Clin Oncol 13:1188-1194, 1995
11. Roeleveld TA, Horenblas S, Meinhardt W, et al: Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients. J Urol 166:2166-2170, 2001
12. Francis R, Bower M, Brunstrom G, et al: Surveillance for stage I testicular germ cell tumours: Results and cost benefit analysis of management options. Eur J Cancer 36:1925-1932, 2000
13. Sharir S, Jewett MA, Sturgeon JF, et al: Progression detection of stage I nonseminomatous testis cancer on surveillance: Implications for the followup protocol. J Urol 161:472-475, 1999
14. Daugaard G, Petersen PM, Rorth M: Surveillance in stage I testicular cancer. APMIS 111:76-83, 2003
15. Colls BM, Harvey L, Skelton CMA, et al: Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand. BJU Int 83:76-82, 1999
16. Read G, Stenning SP, Cullen MH, et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma: Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10:1762-1768, 1992
17. Alexandre J, Fizazi K, Mahe C, et al: Stage I non-seminomatous germ-cell tumours of the testis: Identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 37:576-582, 2001
18. Sturgeon JF, Jewett MA, Alison RE, et al: Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 10:564-568, 1992
19. Nathan H, Pawlik TM: Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 15:415-423, 2008